Nurse Practitioner in Cave City, AR Accepting Medicare
6 Nurse Practitioner nurses found. Showing 1 - 6
 Brittany Nicole Barnett, APRN-FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 63 Dalton Dr, Cave City, AR 72521 Phone: 870-847-3169 |
 Matthew Barnett, NP Nurse Practitioner - Acute Care Medicare: Medicare Enrolled Practice Location: 63 Dalton Dr, Cave City, AR 72521 Phone: 870-283-2196 |
Mrs. Amber Lea Clements-fore, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 307 N Main St, Cave City, AR 72521 Phone: 870-283-5550 Fax: 870-283-6222 |
Sarah Lynn Wycough, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 301 S Main St, Cave City, AR 72521 Phone: 870-283-5353 |
Randi Michele Wright, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 307 N Main St, Cave City, AR 72521 Phone: 870-283-5550 |
Myra E Kendall, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 301 S Main St, Cave City, AR 72521 Phone: 870-283-5353 Fax: 870-283-5988 |
News Archive
MSU scientists discover early cause of intestinal inflammation
Michigan State University scientists have identified an early cause of intestinal inflammation, one of the first stages of inflammatory bowel disease and irritable bowel syndrome, which afflict around 11 percent of the world's population.
Mylan announces FDA approval for Glipizide and Metformin Hydrochloride tablets
Mylan Laboratories has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Glipizide and Metformin Hydrochloride Tablets in 2.5 mg/250 mg, 2.5 mg/500 mg and 5 mg/500 mg strengths.
Fish slime could be a potential source of antibiotics finds study
With the advent of multi-drug resistant bacteria and lack of new antibiotics, researchers have been on the lookout for new molecules that can fight these pathogens. A team of researchers have now identified a slimy mucous coating of young fish as a potential source for antibiotics that could fight resistant infections such as MRSA (Methicillin Resistant Staphylococcus aureus).
Biomatrica announces strategic partnership agreement with In-Q-Tel
Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel. IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.
› Verified 7 days ago